Showing results (781-790 of 926) with videos related to

Sort By:
Pageof 93
Pediatric Infectious Disease|May 1, 1985
Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemiaA M Goorin, B J Hershey, M J Levin, et al.
The American Journal of Medicine|July 20, 1982
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised hostJ D Meyers, J C Wade, C D Mitchell, et al.
The Pediatric Infectious Disease Journal|January 1, 1995
Use of cytomegalovirus immunoglobulin in multiply transfused premature neonatesD R Snydman, B G Werner, H C Meissner, et al.
Vaccine|July 4, 2008
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected childrenMyron J Levin, Lin-Ye Song, Terrence Fenton, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1989
A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operationsM J London, J S Ho, J K Triedman, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Pharmacokinetics of acyclovir suspension in infants and childrenW M Sullender, A M Arvin, P S Diaz, et al.
Transfusion|January 10, 2003
An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigensEufrosina S Umezawa, Sueli F Bastos, Jose R Coura, et al.
Science (New York, N.Y.)|February 11, 2017
A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-prolineB J Levin, Y Y Huang, S C Peck, et al.
The American Journal of Tropical Medicine and Hygiene|March 3, 2004
Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart diseaseAlejandro G Schijman, Carlos A Vigliano, Rodolfo J Viotti, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 13, 2020
Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older AdultsKenneth E Schmader, Myron J Levin, Michael Chen, et al.
Pageof 93